Potent antiretroviral therapy has dramatically improved the prognosis of patients infected
with HIV-1. Primary and secondary prophylaxis against Pneumocystis carinii …

A 25-year-old previously healthy woman is found to have a positive test for human
immunodeficiency virus type 1 (HIV-1) antibody as part of a routine examination for …

Background The one-year survival rate of adults and children with the acquired
immunodeficiency syndrome (AIDS), without antiretroviral therapy, has been about 30 …

Antiretroviral therapy (ART) for HIV/AIDS in developing countries has been rapidly scaled up
through directed public and private resources. Data on the efficacy of ART in developing …

Objective: To describe the long-term efficacy over 5 years of regimens including
combinations of abacavir, lamivudine and/or zidovudine in previously untreated children in …

Background: Despite the high prevalence of HIV in correctional settings, the duration of
therapy and response to various highly active antiretroviral therapy (HAART) regimens in …

Background No large clinical end-point trials have been conducted comparing regimens
among human immunodeficiency virus type 1–positive persons starting antiretroviral …

Objective: To identify optimal first-line therapies based on the rate of virologic success (VS)
and the preservation of future treatment options in antiretroviral therapy (ART)-naive …

HIV/AIDS is considered a worldwide pandemic, with continued increases in the number of
newly diagnosed cases and persons living long-term with the disease. Athletes may be at …

Background High pill burden and side effects often impact on the long-term success of
highly active anti-retroviral therapy (HAART), which has led clinicians to search for more …